Most Read Articles

Viewssort iconArticle
4564R. Scott Kennedy Awarded the 2008 El-Hibri Peace Education Prize
2535Former Dhhs Secretary, Dr. Louis W. Sullivan, Joins Board Of Directors Of Emergent Biosolutions
2452Fuad El-Hibri Ernst & Young Entrepreneur of the Year
1811Bad News Clouds Two Bio Defense Stocks
590Emergent Biosolutions Announces Dr. Stephen Lockhart Joins Company To Lead Commercial Product Development Subsidiary
315Oxford-Emergent Tuberculosis Consortium Signs Commercial License Agreement with Vivalis to Explore Production Of MVA85A TB Vacci
243Fuad el-Hibri, king of anthrax, wins an award from Ernst & Young
228Emergent BioSolutions Announces That BioThrax (Anthrax Vaccine Adsorbed) Receives Market Authorization in India
226Nominations Being Accepted Now for 2010 El-Hibri Peace Education Prize
225Emergent BioSolutions Hosts Biopreparedness Forum for Members of the NATO Parliamentary Assembly
213New TB Vaccine Candidate Enters Phase IIb Proof-of-Concept Trial in South Africa
207EMERGENT BIOSOLUTIONS ANNOUNCES EXPANSION OF BOARD OF DIRECTORS AND APPOINTMENT OF DR. SUE BAILEY TO THE COMPANY’S BOARD OF DIRE
201Washington Launched Me, But I am Proud to be a Lebanese Dreaming of New Technology - Al Anwar
196Emergent BioSolutions hands out bonuses
196Fuad El-Hibri on Twine
194Emergent Biosolutions Delivers Over 3 Million Doses Of Biothrax® To U.S. Department Of Health And Human Services For Strategic N
186October 9, 2008 - Farr Honors Former Santa Cruz Mayor
183Emergent Biosolutions Announces Management Changes
182Lebanese CEO Sees Opportunity in Current Crisis
175Emergent BioSolutions Buys Rival Vaccine for $2 Million
172 Emergent BioSolutions reacts to BARDA's Request for Proposal cancellation
165Fuad El-Hibri Official Bio Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding Int
160Emergent Biosolutions Receives Development Contract From Niaid/Barda To Fund Continued Development Of Anthrax Therapeutic
153Emergent BioSolutions Enhances Manufacturing Infrastructure with Strategic Acquisition in Baltimore
153Emergrnt Biosultions on Answers.com
143EMERGENT BIOSOLUTIONS ANNOUNCES MANAGEMENT CHANGES
130Emergent Biosolutions Acquires Monoclonal Anthrax Product Candidate
129EMERGENT BIOSOLUTIONS ANTICIPATES 2ND QUARTER BIOTHRAX REVENUES OF APPROXIMATELY $20 MILLION BASED ON ACCELERATED DELIVERY TO DE
125Board expands with Election of Fuad El-Hibri
123Maker of anthrax vaccine discusses challenges of marketing overseas
117Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland
117Emergent BioSolutions Inc. (EBS) CEO & Chairman, 10% Owner Fuad El-hibri sells 15,000 Shares
117Joe M. Allbaugh, Former Fema Director, Joins Emergent Biosolutions’ Board Of Directors
116Fuad El-Hibri on Webbiographies
115Fued El-Hibri Profile on Forbes
114Fuad El-Hibri and Healthcare Reform
111Emergent BioSolutions to Participate in June 2010 Investor Conferences
106The El-Hibri Foundation Launches Website
105Emergent Biosolutions Expands Presence In Germany
104Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax
104Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript
104Fuad El-Hibri on Businessweek
103STATEMENT BY FUAD EL-HIBRI, EMERGENT BIOSOLUTIONS CHAIRMAN AND CHIEF EXECUTIVE OFFICER, ON THE PASSING OF ADMIRAL WILLIAM CROWE,
103Nomination Deadline Approaching for 2010 El-Hibri Peace Education Prize
103U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES REMAINS COMMITTED TO PROCUREMENT OF BIOTHRAX® UNDER CURRENT CONTRACT
102Emergent looks to buy Maryland lab
100Fuad El-Hibri on Wikipedia
100Jerome M. Hauer Named To Board Of Directors Of Emergent Biosolutions
100EMERGENT BIOSOLUTIONS’ TYPHOID VACCINE CANDIDATE ACHIEVES ENDPOINTS IN PHASE II CLINICAL STUDY
99Ernst & Young’s Entrepreneur of the Year Fuad El-Hibri
98Maryland Governor Martin O’Malley Leads Ribbon Cutting Ceremony at Emergent’s Baltimore Manufacturing Facility
98Emergent biosolutions announces that department OF HEALTH AND HUMAN SERVICES AND DEPARTMENT OF DEFENSE ISSUED NOTICES OF INTENT
96Emergent BioSolutions moves forward with typhoid vaccine
95Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst & Young Entrepreneur of the Year 2009 Award Winner in
92Fuad El-Hibri is a Washington-Area Success Story
91About Fuad El-Hibri on Atlanta Business Chronicle
89U.S. Government To Purchase Additional 14.5 Million Doses Of Biothrax® Under New Contract Valued At Up To $404 Million
88<a href="http://www.muckety.com/Fuad-El-Hibri/8838.muckety">Fuad El-
87Rene Moawad Foundation (RMF) USA Holds 14th Annual Washington Gala Dinner
87EMERGENT BIOSOLUTIONS SIGNS $448 MILLION THREE YEAR CONTRACT WITH DEPARTMENT OF HEALTH AND HUMAN SERVICES
86Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians
86Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst &amp; Young Entrepreneur of the Year 2009 Award Finalist
85EMERGENT BIOSOLUTIONS ANNOUNCES THE APPOINTMENT OF DENISE LANDRY AS SENIOR VICE PRESIDENT, QUALITY
83Fuad El-Hibri’s Linkedin Profile
82Digg Fuad El-Hibri
81Fuad El-Hibri on Social Networks
79Fuad El-Hibri Earnings Call
79Emergent Revises Upward 2010 Financial Forecast
79Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign Governments
76Fuad El-Hibri El-Hibri Peace Education Prize
75Fuad El-Hibri on Corridor Inc.
74Fuad El-Hibri Profiles
72Emergent BioSolutions and Ninebio Sdn. Bhd. AnnounceJoint Venture in Malaysia.
71Emergent Biosolutions El-Hibri
69EMERGENT BIOSOLUTIONS ANNOUNCES RESULTS FROM ANNUAL MEETING OF STOCKHOLDERS
67Peace Prize awarded to Center for Nonviolence’s Kennedy
61Emergent BioSolutions To Acquire Protein Sciences’ Phase III Recombinant Flu Vaccine Candidate, FluBlok(R), And Related Novel Pl
55EMERGENT BIOSOLUTIONS INC Profile on AOL
47Emergent BioSolutions to Acquire Trubion Pharmaceuticals
38Colman McCarthy to Receive 2010 EL-HIBRI Peace Education Prize
30Emergent BioSolutions Hosts Symposium for Biomedical Research Scholars